Acute Ablation of Langerhans Cells Enhances Skin Immune Responses

Understanding the function of Langerhans cells (LCs) in vivo has been complicated by conflicting results from LC-deficient mice. Human Langerin-DTA mice constitutively lack LCs and develop exaggerated contact hypersensitivity (CHS) responses. Murine Langerin-diptheria toxin receptor (DTR) mice allow for the inducible elimination of LCs and Langerin+ dermal dendritic cells (dDCs) after administration of diphtheria toxin, which results in reduced CHS. When Langerin+ dDCs have partially repopulated the skin but LCs are still absent, CHS returns to normal. Thus, LCs appear to be suppressive in human Langerin-DTA mice and redundant in murine Langerin-DTR mice. To determine whether inducible versus constitutive LC ablation explains these results, we engineered human Langerin-DTR mice in which diphtheria toxin ablates LCs without affecting Langerin+ dDCs. The inducible ablation of LCs in human Langerin-DTR mice resulted in increased CHS. Thus, LC-mediated suppression does not require their absence during ontogeny or during the steady-state and is consistent with a model in which LCs actively suppress Ag-specific CHS responses.

[1]  B. Malissen,et al.  Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity. , 2010, The Journal of allergy and clinical immunology.

[2]  M. Shlomchik,et al.  Langerhans Cells Suppress Contact Hypersensitivity Responses Via Cognate CD4 Interaction and Langerhans Cell-Derived IL-101 , 2009, The Journal of Immunology.

[3]  B. Malissen,et al.  Langerhans cells are critical in the development of atopic dermatitis‐like inflammation and symptoms in mice , 2009, Journal of cellular and molecular medicine.

[4]  L. Bockenstedt,et al.  Langerhans Cell Deficiency Impairs Ixodes scapularis Suppression of Th1 Responses in Mice , 2009, Infection and Immunity.

[5]  Clare L. Bennett,et al.  Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions , 2009, Proceedings of the National Academy of Sciences.

[6]  J. Wagner,et al.  Calcitonin Gene-Related Peptide Biases Langerhans Cells toward Th2-Type Immunity1 , 2008, The Journal of Immunology.

[7]  H. Ueno,et al.  Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. , 2008, Immunity.

[8]  A. Kissenpfennig,et al.  Insights into Langerhans cell function from Langerhans cell ablation models , 2008, European journal of immunology.

[9]  M. Shlomchik,et al.  Langerhans cells are not required for efficient skin graft rejection. , 2008, The Journal of investigative dermatology.

[10]  S. Jameson,et al.  Langerin Expressing Cells Promote Skin Immune Responses under Defined Conditions1 , 2008, The Journal of Immunology.

[11]  N. Romani,et al.  Expression of Langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains , 2008, Immunology.

[12]  K. Hogquist,et al.  Identification of a novel population of Langerin+ dendritic cells , 2007, The Journal of experimental medicine.

[13]  E. Devilard,et al.  The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells , 2007, The Journal of experimental medicine.

[14]  F. Ginhoux,et al.  Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state , 2007, The Journal of experimental medicine.

[15]  Clare L. Bennett,et al.  Langerhans Cells Are Required for Efficient Presentation of Topically Applied Hapten to T Cells1 , 2007, The Journal of Immunology.

[16]  R. Flavell,et al.  Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells , 2007, The Journal of experimental medicine.

[17]  R. Flavell,et al.  Autocrine/paracrine TGFb1 is required for the development of epidermal Langerhans cells , 2007 .

[18]  N. Romani,et al.  Epidermal Langerhans cells--changing views on their function in vivo. , 2006, Immunology letters.

[19]  S. Ju,et al.  A major lung CD103 (αE)-β7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins , 2006, The Journal of Immunology.

[20]  K. Hogquist,et al.  Conditioning of Langerhans Cells Induced by a Primary CD8 T Cell Response to Self-Antigen In Vivo4 , 2006, The Journal of Immunology.

[21]  S. Ju,et al.  A Major Lung CD103 (αE)-β7 Integrin-Positive Epithelial Dendritic Cell Population Expressing Langerin and Tight Junction Proteins1 , 2006, The Journal of Immunology.

[22]  M. Shlomchik,et al.  Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. , 2005, Immunity.

[23]  N. Romani,et al.  Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. , 2005, The Journal of investigative dermatology.

[24]  Clare L. Bennett,et al.  Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity , 2005, The Journal of cell biology.

[25]  P. Perrin,et al.  Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.

[26]  Steffen Jung,et al.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.

[27]  E. Bröcker,et al.  Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. , 2002, Blood.

[28]  M. Mattei,et al.  Identification of Mouse Langerin/CD207 in Langerhans Cells and Some Dendritic Cells of Lymphoid Tissues1 , 2002, The Journal of Immunology.

[29]  Michel C. Nussenzweig,et al.  Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.